Hi, I may be starting on a clinical trial (NCT04663997) and there are a few terms I'm not familiar with. Here's a few secondary outcome measures.
Progression-free survival rate at 6 months defined by PCWG 3 [ Time Frame: 6 months ]
Progression-free survival rate at 6 months defined by RECIST 1.1 [ Time Frame: 6 months ]
Second rPFS in patients who meet the criteria for rPFS and cross over to the alternate therapy [ Time Frame: 3 years ]
Anyone have details on these terms? Thanks.